FindTrial
Sign In

Assessment of Adverse drug reactions, drug-drug Interactions and medication adherence outcomes among elderly HIV seropositive patients in comparison with young HIV seropositive patients undergoing highly active antiretroviral therapy.

Assessment of adverse drug reactions, drug-drug interactions and medication adherence outcomes among elderly HIV seropositive patients in comparison with young HIV seropositive patients undergoing highly active antiretroviral therapy.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/01/011169
Enrollment
300
Registered
2018-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- HIV seropositive patients

Interventions

None listed

Sponsors

Kasturba medical college Kasturba Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: HIV seropositive patients (HIV-SPP) patients above 18 years of age undergoing Highly active antiretroviral therapy (HAART) treatment will be included.

Exclusion criteria

Exclusion criteria: HIV-SPP who were not on HAART, with chronic-renal-disease, chronic-kidney-disease, rheumatoid-arthritis, cancer, on traditional alternative medicines, pregnant women, who refused for medication adherence outcome assessment will be excluded.

Design outcomes

Primary

MeasureTime frame
ADRs and CS-DDIs to HAART will be assessed and compared between both groups.Timepoint: Clinical data collection during the hospital stay and/or follow up during the study period.—

Secondary

MeasureTime frame
Medication adherence to HAART will be assessed using AIDS Clinical Trail Group (ACTG) adherence questionnaire.Timepoint: Clinical data collection during the hospital stay and/or follow up during the study period.—

Countries

India

Contacts

Public ContactSanju Rajan

Manipal College of Pharmaceutical Sciences

rajesh.r@manipal.edu91-820-2922403

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026